Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

FDA allows IND for Cougar Biotechnology's noscapine

July 25, 2007

Phase I/II trial of PMEG prodrug scheduled to begin this month

July 24, 2007

First-in-human trial of MLN-8237 under way

July 24, 2007

EMEA approval of Genta's MAA for Genasense requires additional trial

July 24, 2007

Yondelis recommended for E.U. approval in soft tissue sarcoma

July 23, 2007

Avastin recommended for E.U. approval in NSCLC

July 23, 2007

Mechanism behind orlistat's antitumor activity explored

July 23, 2007

Recent patents impart new therapeutic agents for cancer

July 23, 2007

Treatment begins in phase III trial of Litx for metastatic colorectal cancer

July 20, 2007

Millennium begins phase III trial of Velcade for newly diagnosed MM

July 19, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...